Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02798328 · ClinicalTrials.gov registry record
Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System
A clinical trial, sponsored by Haemonetics Corporation.
- Completed
- Registry status
- 385
- Enrollment target
NCT02798328 is a clinical trial that has completed, run by Haemonetics Corporation. The registered enrollment target is 385 participants.
The verdict
NCT02798328 has completed, sponsored by Haemonetics Corporation.
- COMPLETED
- Registry status
- 385 participants
- Enrollment target
Study Summary
Observational trial to evaluate the effectiveness of the TEG6s DOAC cartridge to detect and classify the presence of DOAC drugs in a subject.
Interventions
- DEVICE TEG6s DOAC Cartridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02798328
The ClinicalTrials.gov registry entry for NCT02798328 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 385 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Haemonetics Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TEG6s DOAC Cartridge is the first listed.
NCT02798328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02798328 about?
NCT02798328 is a clinical study titled "Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System". Observational trial to evaluate the effectiveness of the TEG6s DOAC cartridge to detect and classify the presence of DOAC drugs in a subject.
What is the current status of trial NCT02798328?
This trial is currently completed. The enrollment target is 385 participants. The study started on 2016-08. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02798328?
The interventions under investigation include: TEG6s DOAC Cartridge (DEVICE).
Who is sponsoring clinical trial NCT02798328?
This trial is sponsored by Haemonetics Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.